- (-%)

Range - - -   (-%)
Open -
Previous Close 0.198
Buy Price 0.198
Buy Volume 38.5
Sell Price 0.200
Sell Volume 4.6
Volume -
Value -
Measurement Type Value
EPS (SGD) -0.005
Trailing EPS (SGD) -0.005
NAV (SGD) 0.032
Cash In Hand (SGD) 0.023
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 6.226
Price / Cash In Hand 8.684
Issued & Paid-up Shares 644,594,000
Treasury Shares -
Market Cap (M) 127.63
Par Value (SGD) n.a.
Beta - 75 Days 0.83
R-Squared - 75 Days(%) 3.96
Beta - 500 Days 0.512
R-Squared - 500 Days(%) 1.13
ISIN Code SG1BD9000009
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 18 Sep 2019 10:58.
Data powered by
View All Events

About IX Biopharma

iX Biopharma Ltd. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and commercialization of therapies for the treatment of acute and breakthrough pain, and male erectile dysfunction. Its segments include Specialty Pharmaceutical and Chemical Analysis segments. The Specialty Pharmaceutical segment is engaged in the development, manufacturing and sale of pharmaceutical products. The Chemical Analysis segment is engaged in the provision of laboratory testing services. Its products are Wafermine, which is a sublingual ketamine oral wafer that contains the non-opioid drug for the management of moderate to severe pain; Bnox, which is a sublingual buprenorphine oral wafer that is developed as a formulation for moderate to severe pain; PheoniX, which is used for the treatment of male erectile dysfunction; WaferRest, which is used for the alleviation of jet lag and improving sleep quality, and Wafernyl, which is used for breakthrough cancer pain.

Loading Chart...

IX Biopharma(42C)
Target Price
Add Stop Loss
Time Frames